From: Serum level of hepcidin in cirrhotic patients as a marker for hepatocellular carcinoma
 | N | Hepcidin (ng/ml) | Test of sig. | p | |
---|---|---|---|---|---|
Mean ± SD | Median (min.–max.) | ||||
BCLC | |||||
 A | 5 | 1.04 ± 0.12 | 1.02 (0.86–1.19) | H = 0.116 | 0.990 |
 B | 5 | 1.02 ± 0.08 | 1.01 (0.96–1.16) | ||
 C | 7 | 1.44 ± 1.14 | 1.0 (0.82–4.0) | ||
 D | 13 | 1.10 ± 0.18 | 1.09 (0.88–1.45) | ||
Tumor number | |||||
 1 | 10 | 1.40 ± 0.93 | 1.14 (0.88–4.0) | H = 4.870 | 0.182 |
 2 | 6 | 1.03 ± 0.17 | 1.0 (0.86–1.36) | ||
 3 | 3 | 1.13 ± 0.15 | 1.09 (1.01–1.30) | ||
 > 3 | 11 | 1.00 ± 0.10 | 0.98 (0.82–1.18) | ||
Distant metastases | |||||
 No | 27 | 1.17 ± 0.58 | 1.02 (0.82–4.0) | U = 24.0 | 0.283 |
 Yes | 3 | 1.0 ± 0.08 | 0.96 (0.95–1.09) |